https://www.selleckchem.com/pr....oducts/dibutyryl-cam
Many children living with HIV (CLWH) display impaired cognition. Although early combination antiretroviral therapy (ART) produces improved cognitive outcomes, more long-term outcome data are needed. After concluding the Children with HIV Early antiRetroviral (CHER) trial in 2011, we investigated cognitive performance, at seven and nine years of age. Participants had been randomized to deferred ART (ART-Def; n=22); immediate time-limited ART for 40weeks (ART-40W; n=3 and immediate time-limited ART for 96weeks (ART-96
Like
Comment
Share
